drugset / Trial / NCT04660370

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348

NCT04660370

Phase 1 Completed 70 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A Clinical Trial to evaluate the Pharmacokinetics and Tolerability of CKD-348

Timeline

Start
2021-01-09
Primary completion
2021-02-24
Completion
2021-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-348 Unknown 1 unknown Oral
Subject CKD-828 Unknown Oral
Subject D097 Unknown Oral
Subject D337 Unknown Oral